参考文献/References:
[1]柳子静,郭金成,张海滨,等.环境因素对急性心肌梗死发病的影响[J].中华全科医学,2017,15(4):690-692.[2]Rogers T,Dworakowski R,Khan H,et al.ST segment elevation myocardial infarction to bite off more than one can chew[J].Circulation,2013,128(21):2345-2346.[3]Pinto DS,Frederick PD,Chakrabarti AK,et al.Benefit of transferring ST-segment-elevation myocardial infarction patients for percutaneous coronary intervention compared with administration of onsite fibrinolytic declines as delays increase[J].Circulation,2011,124(23):2512-2521.[4]Tian C,Song J,He D,et al.Predictive Value of Mean Platelet Volume/Platelet Count for Prognosis in Acute Myocardial Infarction[J].Int Heart J,2018,59(2):286-292.[5]Klingenbergk R,Aghlmandi S,Raber L,et al.Improved risk stratification of patients withacute coronary syndromes using a combination of hsTnT,NT-proBNP and hsCRPwiththe GRACE score[J].Eur Heart J Acute Cardiovasc Care,2018,7(2):129-138.[6]Cohen M,Gensini GF,Maritz F,et al.Prospective evaluation of clinical outcomes after acute ST-elevation myocardial infarction in patients who are ineligible for reperfusion therapy: preliminary results from the TETAMI registry and randomized trial[J].Circulation,2003,108:14-21.[7]Zhou SS,Tian F,Chen YD,et al.Combination therapy reduces the incidence of no-reflow after primary per-cutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction[J].J Geriatr Cardiol,2015,12(2):135-142.[8]Bahrehmand M,Sadeghi E,Shafiee A,et al.Predictors of delayedand no-reflow as recognized with Thrombolysis in Myocardial Infarction[TIMI]flow grade following Pfimary Percutaneous Coronary Angioplasty[J].J Med Life,2015,8(3):59-65.[9]Wagdy S,Sobhy M,Loutfi M.Neutrophil/lymphocyte ratio as a predictor of in-hospital major adverse cardiac events,new-onset atrial fibrillation,and no-reflow phenomenon in patients with ST elevation myocardial infarction[J].Clin Med Insights Cardiol,2016,10:19-22.[10]Shah B,Oberweis B,Tummala L,et al.Mean platelet volume and long-term mortality in patients undergoing percutaneous coronary intervention[J].Am J Cardiol,2013,111:185-189.[11]Bressl E,Mangiacapra F,RIicottin E,et al.Impact of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio on 5-year clinical outcomes of patients with stable coronary artery disease undergoing elective percutaneous coronary intervention[J].J Cardiovasc Transl Res,2018,11(6):517-523.[12]武金娥,高凡,吕军,等.急性ST段抬高型心肌梗死患者外周血白细胞、血小板和血红蛋白含量与预后的关系[J].中国循证心血管医学杂志,2020,12(5):620-622.[13]陈艳梅,孙环,李丽,等.急性心肌梗死患者PCI术后二级预防现状及心血管事件影响因素研究[J].中国疗养医学,2021,30(1):22-24.[14]邱军杰,康晓军,王西辉.急性心肌梗死患者经皮冠状动脉介入治疗后红细胞分布宽度和梗死相关血管预后的关系[J].岭南心血管病杂志,2018,24(5):506-510.[15]刘红军,杨杰.平均血小板体积联合Gensini评分预测ST段抬高型心肌梗死患者急诊经皮冠状动脉介入术近期预后[J].中国介入影像与治疗学,2019,16(3):139-143.[16]郑艳颖,吴威,张婷,等.血小板参数检测在急性心肌梗死PCI术后不良事件中的预测价值[J].四川生理科学杂志,2021,43(7):1201-1203.[17]陈鑫森,邵萌,张天,等.血液学参数预测急性ST段抬高型心肌梗死患者经皮冠状动脉介入治疗术后发生主要不良心血管事件的价值研究[J].中国全科医学,2020,23(27):3389-3395.[18]李华平,薛成年,陆春雷.血小板相关指标及Gensini评分在PCI术后预后评估中的作用[J].中国循证心血管医学杂志,2021,13(9):1042-1045.[19]宋红星,张杰,马龙飞,等.PLR、NLR在急性心肌梗死PCI术中无复流和术后MACCE中的预测价值[J].中国循证心血管医学杂志,2018,10(4):484-487,492.[20]刘瑞霞,范晓英.血小板-淋巴细胞比值预测急性ST段抬高型心肌梗死患者直接PCI术后心血管不良事件的价值[J].中华保健医学杂志,2020,22(5):506-508.[21]孙亚召,孙东旭,黄淑田.血小板与淋巴细胞比值对冠状动脉病变及介入治疗预后的预测价值[J].中华老年心脑血管病杂志,2019,21(5):490-493.[22]Ayca B,Akin F,Celik O,et al.Platelet to lymphocyte ratio as a prognostic marker in primary percutaneous coronary intervention[J].Platelets,2015,26(7):638-644.[23]Ugur M,Gul M,Bozbay M,et al.The relationship between platelet to lymphocyte ratio and the clinical outcomes in ST elevation myocardial infarction underwent primary coronary intervention[J].Blood Coagul Fibrinolysis,2014,25(8):806-811.[24]Ozcan Cetin EH,Cetin MS,Aras D,et al.Platelet to lymphocyte ratio as a prognostic marker of in-hospital and long-term major adverse cardiovascular events in ST-segment elevation myocardial infarction[J].Angiology,2016,67(4):336-345.[25]Toprak C,Tabakci MM,Simsek Z,et al.Platelet/lymphocyte ratio was associated with impaired myocardial perfusion and both in-hospital and long-term adverse outcome in patients with ST-segment elevation acute myocardial infarction undergoing primary coronary intervention[J].Postepy Kardiol Interwencyjnej,2015,11(4):288-297.[26]Maimaiti A,Li Y,Wang YT,et al.Association of platelet-to-lymphocyte count ratio with myocardial reperfusion and major adverse events in patients with acute myocardial infarction: a two-centre retrospective cohort study[J].BMJ Open,2019,9(9):e025628.[27]亢爱春,李阳,季汉华,等.NLR与NSTE-ACS冠脉病变程度及PCI术后心血管终点事件的相关性[J].河北医药,2020,42(8):1206-1209.[28]任良强,侯晓晓,乔平,等.WMR、RDW、NLR水平与急性心肌梗死患者PCI术后发生主要不良心血管事件的关系[J].中国现代医学杂志,2022,32(2):74-79.[29]许云梦,徐晓东,方中,等.白细胞计数/平均血小板体积比值及中性粒细胞/淋巴细胞比值评估急性冠脉综合征患者介入治疗预后的价值[J].安徽医学,2017,38(1):33-37.[30]罗勤,李姣,周国忠,等.急性ST段拾高型心肌梗死患者近期预后的影响因素[J].实用临床医药杂志,2020,24(23):81-84.[31]陈小丽,李建国,任艳琴.老年STEMI患者PCI术前PDW、NLR对院内MACE的预测价值[J].医学研究杂志,2020,49(6):96-99.[32]陈鑫森,邵萌,张天,等.平均血小板体积与淋巴细胞比值联合中性粒细胞与淋巴细胞比值对急性STEMI患者急诊PCI术后短期预后的预测价值[J].中国急救医学,2020,40(1):35-43.[33]占凌辉,侯炳波,路丹,等.中性粒细胞/淋巴细胞比值对PCI术后ACS患者预后评价的价值[J].心血管康复医学杂志,2020,29(2):146-150.[34]陈鑫森,黄钟,李桂花.中性粒细胞/淋巴细胞比值联合平均血小板体积对急性STEMI患者PCI术后发生院内主要不良心血管事件的预测价值[J].中国全科医学,2020,23(9):1117-1126.[35]余辉,李宾,甘受益,等.中性粒细胞与淋巴细胞比值在急性心肌梗死PCI术中无复流和术后MACE中的预测价值[J].心血管康复医学杂志,2020,29(4):458-462.[36]李其华,易秋艳,陈见红,等.平均血小板体积对经皮冠状动脉介入治疗患者发生主要不良心血管事件的预测价值[J].山东医药,2017,57(1):56-58.[37]徐海燕,陈雨,蒙涛,等.平均血小板体积联合SYNTAX积分评估介入治疗非ST段抬高心肌梗死患者远期预后的价值[J].中国心血管病研究,2015,13(9):831-835.[38]王文斌,菅宏伟,程国杰,等.血小板参数对急性心肌梗死患者急诊介入治疗后主要不良心脏事件的影响[J].中国医药导报,2018,15(17):48-51.[39]Dogan A,Aksoy F,Icli A,et al.Mean platelet volume is associated with culprit lesion severity and cardiac events in acute coronary syndromes without ST elevation[J].Blood Coagul Fibrinolysis,2012,23:324-330.[40]Tekbas E,Kara AF,Ariturk Z,et al.Mean platelet volume in predicting short-and long-term morbidity and mortality in patients with or without ST-segment elevation myocardial infarction[J].Scand J Clin Lab Invest,2011,71:613-619.[41]Cesari FM,Gori R,Caporale AM,et al.Reticulated platelets predict cardiovascular death in acute coronary syndrome patients: Insights from the AMI-florence 2 study[J].J ThrombHaemost,2013,109:846-853.[42]Vakili H,Kowsari R,Namazi M,et al.Could mean platelet volume predicts impaired reperfusion and in-hospital major adverse cardiovascular event in patients with primary percutaneous coronary intervention after ST-elevation myocardial infarction[J].J Tehran Heart Cent,2009,4:17-23.[43]Fadaei R,Parvaz E,Emamgholipour S,et al.The mRNA expression and circulating levels of visfatin and their correlation with coronary artery disease severity and 25-Hydroxyvitamin D[J].Horm Metab Res,2016,48(4):269-274.[44]徐健,赵世杰,牛一蒙,等.血小板淋巴细胞比值与老年急性冠状动脉综合征患者冠状动脉介入治疗围术期心肌梗死的相关分析及其预测价值[J].中国医科大学学报,2019,48(8):719-725. [45]Turak O,Ozcan F,Isleyen A,et al.Usefulness of the neutrophilto-lymphocyte ratio to predict bare-metal stent restenosis[J].Am J Cardiol,2012,110(10):1405-1410. [46]Ranjith MP,Divyaraj R,Mathew D,et al.Mean platelet volume and cardiovascular outcomes in acute myocardial infarction[J].Heart Asia,2016,8(1):16-20.
相似文献/References:
[1]郑 新,张 颖.慢阻肺患者PSQI评分与NLR、PLR、CRP水平及急性加重频率的相关性[J].医学信息,2020,33(12):103.[doi:10.3969/j.issn.1006-1959.2020.12.031]
ZHENG Xin,ZHANG Ying.Correlation of PSQI Score with NLR,PLR,CRP Level and Frequency of Acute Exacerbation in COPD Patients[J].Journal of Medical Information,2020,33(06):103.[doi:10.3969/j.issn.1006-1959.2020.12.031]
[2]王 晶.垂体后叶素联合硝酸甘油治疗肝硬化上消化道出血的效果[J].医学信息,2020,33(19):147.[doi:10.3969/j.issn.1006-1959.2020.19.046]
WANG Jing.Effect of Pituitrin and Nitroglycerin on Upper Gastrointestinal Bleeding in Cirrhosis[J].Journal of Medical Information,2020,33(06):147.[doi:10.3969/j.issn.1006-1959.2020.19.046]
[3]侯婷婷,刘尚全.PLR与2型糖尿病合并颈动脉粥样斑块患者的相关性[J].医学信息,2021,34(04):103.[doi:10.3969/j.issn.1006-1959.2021.04.027]
HOU Ting-ting,LIU Shang-quan.The Correlation Between PLR and Type 2 Diabetes Mellitus with Carotid Atherosclerotic Plaque[J].Journal of Medical Information,2021,34(06):103.[doi:10.3969/j.issn.1006-1959.2021.04.027]
[4]杨 许,吴书胜,闫 滢,等.胃癌术前外周血NLR、PLR、FIB与术后发生卵巢转移时间的相关性分析[J].医学信息,2021,34(23):39.[doi:10.3969/j.issn.1006-1959.2021.23.011]
YANG Xu,WU Shu-sheng,YAN Ying,et al.Correlation Analysis Between Preoperative Peripheral Blood NLR,PLR,FIB and Postoperative Ovarian Metastasis Time of Gastric Cancer[J].Journal of Medical Information,2021,34(06):39.[doi:10.3969/j.issn.1006-1959.2021.23.011]
[5]陈海燕,翟长云,王伟奇,等.升板方联合重组人白介素-11治疗化疗后血小板减少症的效果研究[J].医学信息,2022,35(03):172.[doi:10.3969/j.issn.1006-1959.2022.03.046]
CHEN Hai-yan,ZHAI Chang-yun,WANG Wei-qi,et al.Study on the Effect of Shengbanfang Combined with Recombinant Human Interleukin-11in the Treatment of Thrombocytopenia After Chemotherapy[J].Journal of Medical Information,2022,35(06):172.[doi:10.3969/j.issn.1006-1959.2022.03.046]
[6]王晓雪,王芝涛,秦 慧.血小板与淋巴细胞比值在多发性骨髓瘤预后中的价值[J].医学信息,2022,35(12):109.[doi:10.3969/j.issn.1006-1959.2022.12.026]
WANG Xiao-xue,WANG Zhi-tao,QIN Hui.Prognostic Value of Platelet to Lymphocyte Ratio in Multiple Myeloma[J].Journal of Medical Information,2022,35(06):109.[doi:10.3969/j.issn.1006-1959.2022.12.026]
[7]曹鸣菲,雷德财,董秋月,等.NSCLC患者外周血血小板相关参数与临床病理特征的关系[J].医学信息,2023,36(18):90.[doi:10.3969/j.issn.1006-1959.2023.18.016]
CAO Ming-fei,LEI De-cai,DONG Qiu-yue,et al.The Relationship Between Peripheral Blood Platelet Related Parameters and Clinicopathological Features in NSCLC Patients[J].Journal of Medical Information,2023,36(06):90.[doi:10.3969/j.issn.1006-1959.2023.18.016]
[8]徐 松,豆正莉.NLR、PLR、MLR、SII在结直肠癌诊断中的应用价值[J].医学信息,2024,37(13):85.[doi:10.3969/j.issn.1006-1959.2024.13.016]
Application Value of NLR,PLR,MLR and SII in the Diagnosis of Colorectal Cancer.Application Value of NLR, PLR, MLR and SII in the Diagnosis of Colorectal Cancer[J].Journal of Medical Information,2024,37(06):85.[doi:10.3969/j.issn.1006-1959.2024.13.016]
[9]刘锦程,路 亮.红细胞分布宽度与淋巴细胞比值、血小板与淋巴细胞比值联合癌胚抗原对结直肠癌的诊断价值[J].医学信息,2024,37(13):138.[doi:10.3969/j.issn.1006-1959.2024.13.029]
Diagnostic Value of Red Blood Cell Distribution Width to Lymphocyte Ratio,Platelet to Lymphocyte Ratio Combined with Carcinoembryonic Antigen in Colorectal Cancer.Diagnostic Value of Red Blood Cell Distribution Width to Lymphocyte Ratio, Platelet to Lymphocyte Ratio Combined with Carcinoembryonic Antigen in Colorectal Cancer[J].Journal of Medical Information,2024,37(06):138.[doi:10.3969/j.issn.1006-1959.2024.13.029]